Source: Annual Congress 2004 - Biological markers in diagnosis, monitoring and treatment of respiratory disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Tonelli, M. L. Bartoli, F. L. Dente, B. Vagaggini, A. Di Franco, M. Taccola, A. Guerra, P. L. Paggiaro (Pisa, Italy). Acute reversibility of airflow limitation and sputum eosinophilia in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: Suppl. 48, 3559

Member's Comments

No comment yet.

Related content which might interest you: Asthma versus chronic obstructive pulmonary disease Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=195 Year: 2003 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 Quantification of airflow limitation in chronic obstructive pulmonary disease Source: International Congress 2018 – Innovations in equipment and their application Year: 2018 Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Bronchial hyperreactivity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease Source: International Congress 2017 – Lung function testing Year: 2017 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Response of lung volumes in chronic obstructive pulmonary disease patients with improvement of airflow limitation Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 Cough reflex sensitivity in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Chronic obstructive pulmonary disease with preserved lung function, severe hypoxemia and emphysema Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 Minimal bronchiectasis in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 893-894 Year: 2004